Sainsbury, H. Treatment of Insanity. J Ment Sci
1904; 50: 565.
Moncrieff, J. Lithium: evidence reconsidered. Br J Psychiatry
1997; 171: 113–9.
Young, AH, Hammond, JM. Lithium in mood disorders: increasing evidence base, declining use?
Br J Psychiatry
2007; 191: 474–6.
Kapusta, ND, Mossaheb, N, Etzersdorfer, E, Hlavin, G, Thau, K, Willeit, M, et al. Lithium in drinking water and suicide mortality. Br J Psychiatry
2011; 198: 346–350.
Goodwin, GM. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry
1994; 164: 149–52.
Geddes, JR, Goodwin, GM, Rednell, J, Azorin, JM, Cipriani, A. Ostacher, MJ, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomized open-label trial. Lancet
2010; 375: 385–95.
Young, AH, McElroy, SL, Bauer, M, Philips, N, Chang, W, Olausson, B, et al. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry
2010; 71: 150–62.
Nunes, PV, Forlenza, OV, Gattaz, WF. Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br J Psychiatry
2007; 190: 359–60.
Lovestone, S, Davis, DR, Webster, MT, Kaech, S, Brion, JP, Matus, A, et al. Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations. Biol Psychiatry
1999; 45: 995–1003.
Kessing, LV, Sondergard, L, Forman, JL, Anderson, PK. Lithium treatment and risk of dementia. Arch Gen Psychiatry
2008; 65: 1331–5.
Kessing, LV, Forman, JL, Anderson, PK. Does Lithium protect against dementia?
2010; 12: 87–94.
Macdonald, A, Briggs, K, Poppe, M, Higgins, A, Velayudhan, L, Lovestone, S. A feasibility and tolerability study of lithium in Alzheimer's disease. Int J Geriatr Psychiatry
2008; 23: 704–11.
Hamel, H, Ewers, M, Burger, K, Annas, P, Mortberg, A, Bogstedt, A, et al. Lithium trial in Alzheimer's disease: a randomized single-blind, placebo controlled, multicenter 10-week study. J Clin Psychiatry
2009; 70: 922–31.
Forlenza, OV, Diniz, BS, Radanovic, M, Santos, FS, Talib, LL, Gattaz, WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry
2011; 198: 351–356.
Macritchie, KAN, Lloyd, AJ, Bastin, ME, Vasudev, K, Gallagher, P, Eyre, R, et al. White matter microstructural abnormalities in euthymic bipolar disorder. Br J Psychiatry
2010; 196: 52–8.
Severus, WE, Lipkovich, LA, Licht, RW, Young, AH, Greil, W, Ketter, T, et al. In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al 2005. Eur Psychiatry
2010; 25: 443–9.
Ohgami, H, Terao, T, Shiotsuki, I, Ishii, N, Iwata, N. Lithium Levels in drinking water and risk of suicide. Br J Psychiatry
2009; 194: 464–5.
O'Brien, JT, Burns, A. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol